Torthaí cuardaigh - Sihem Ait‐Oudhia

  • 1 - 8 toradh as 8 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Mechanisms, monitoring, and management of tyrosine kinase inhibitors-associated cardiovascular toxicities

    Mechanisms, monitoring, and management of tyrosine kinase inhibitors-associated cardiovascular toxicities de réir Maher Chaar, Jeff Kamta, Sihem Ait‐Oudhia

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Current advances in biomarkers for targeted therapy in triple-negative breast cancer

    Current advances in biomarkers for targeted therapy in triple-negative breast cancer de réir Brett Fleisher, Charlotte H. Clarke, Sihem Ait‐Oudhia

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization

    In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization de réir Hardik Mody, Tanaya R. Vaidya, Sihem Ait‐Oudhia

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy

    Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy de réir Marianela Robainas, Rafael Otano, Stephen Bueno, Sihem Ait‐Oudhia

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer

    Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer de réir Yesenia L. Franco, Tanaya R. Vaidya, Sihem Ait‐Oudhia

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches

    Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches de réir Jeff Kamta, Maher Chaar, Anusha Ande, Deborah A. Altomare, Sihem Ait‐Oudhia

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring

    Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring de réir Nadine Wenningmann, Merle Knapp, Anusha Ande, Tanaya R. Vaidya, Sihem Ait‐Oudhia

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan

    Expansion of the neonatal platelet mass is achieved via an extension of platelet lifespan de réir Zhijian Liu, Karin M. Hoffmeister, Zhongbo Hu, Donald E. Mager, Sihem Ait‐Oudhia, Marlyse A. Debrincat, Irina Pleines, Emma C. Josefsson, Benjamin T. Kile, Joseph E. Italiano, Haley E. Ramsey, Renata Grozovsky, Peter Veng‐Pedersen, Chaitanya Chavda, Martha Sola‐Visner

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: